Immucell settles contamination insurance claim, to pay additional $426,587

ImmuCell (ICCC) announced that it has settled an insurance claim covering some of the losses incurred from production contamination events. The company settled a long outstanding insurance claim related to previously disclosed contamination events in its production process incurred from late 2022 through April of 2024. The company has accepted a settlement in the amount of $426,587, which is in addition to the $250,000 that was paid on this claim and recognized for financial statement purposes during the third quarter of 2023.